These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

869 related articles for article (PubMed ID: 28551500)

  • 21. Adjunctive brivaracetam in focal and generalized epilepsies: A single-center open-label prospective study in patients with psychiatric comorbidities and intellectual disability.
    Foo EC; Geldard J; Peacey C; Wright E; Eltayeb K; Maguire M
    Epilepsy Behav; 2019 Oct; 99():106505. PubMed ID: 31493736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An audit of lamotrigine, levetiracetam and topiramate usage for epilepsy in a district general hospital.
    Chappell B; Crawford P
    Seizure; 2005 Sep; 14(6):422-8. PubMed ID: 16087359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
    Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
    Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
    Baulac M; Byrnes W; Williams P; Borghs S; Webster E; De Backer M; Dedeken P
    Acta Neurol Scand; 2017 Apr; 135(4):434-441. PubMed ID: 27714769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of generalized tonic-clonic seizures in refractory focal epilepsy: a meta-analysis.
    Hemery C; Ryvlin P; Rheims S
    Epilepsia; 2014 Nov; 55(11):1789-99. PubMed ID: 25182978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study.
    Liguori C; Izzi F; Manfredi N; D'Elia A; Mari L; Mercuri NB; Fabio P
    Epilepsy Behav; 2018 Mar; 80():173-176. PubMed ID: 29414548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy for tonic-clonic seizures.
    Rheims S; Ryvlin P
    Expert Opin Pharmacother; 2014 Jul; 15(10):1417-26. PubMed ID: 24798217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction?
    Novy J; Patsalos PN; Sander JW; Sisodiya SM
    Epilepsy Behav; 2011 Jan; 20(1):20-3. PubMed ID: 21056937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
    Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
    Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticonvulsant drugs for generalized tonic-clonic epilepsy.
    Coppola G; Piccorossi A; Operto FF; Verrotti A
    Expert Opin Pharmacother; 2017 Jun; 18(9):925-936. PubMed ID: 28481729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study.
    Belcastro V; Pisani LR; Bellocchi S; Casiraghi P; Gorgone G; Mula M; Pisani F
    J Neurol; 2017 May; 264(5):921-927. PubMed ID: 28315958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
    Brigo F; Bragazzi NL; Nardone R; Trinka E
    Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs.
    Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J
    Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing Safety and Efficacy of "Third-Generation" Antiepileptic Drugs: Long-Term Extension and Post-marketing Treatment.
    Kwok CS; Johnson EL; Krauss GL
    CNS Drugs; 2017 Nov; 31(11):959-974. PubMed ID: 29204953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive lacosamide--5 years' clinical experience.
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Res; 2014 Oct; 108(8):1385-91. PubMed ID: 25064538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-sensitivity of psychiatric and behavioral side effects with antiepileptic drug use.
    Chen B; Choi H; Hirsch LJ; Legge A; Buchsbaum R; Detyniecki K
    Seizure; 2018 Nov; 62():38-42. PubMed ID: 30273800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levetiracetam monotherapy--outcomes from an epilepsy clinic.
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of psychiatric and behavioral adverse effects of antiepileptic drugs monotherapy: Could they have a neuroendocrine correlation in persons with epilepsy?
    Sarangi SC; Kaur N; Tripathi M
    Epilepsy Behav; 2019 Nov; 100(Pt A):106439. PubMed ID: 31574428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study.
    Bedetti C; Romoli M; Maschio M; Di Bonaventura C; Nardi Cesarini E; Eusebi P; Siliquini S; Dispenza S; Calabresi P; Costa C
    Eur J Neurol; 2017 Oct; 24(10):1283-1289. PubMed ID: 28796376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-Year Retention Study of Adjunctive Perampanel Treatment in Epilepsy Patients.
    Kim DW; Oh J
    Clin Neuropharmacol; 2018; 41(1):10-13. PubMed ID: 29194110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.